Literature DB >> 16850641

Development of national guidelines for the prevention and control of nosocomial infections.

Somwang Danchaivijitr1, Yong Rongrungruang, Susan Assanasen, Paitoon Bunma, Somporn Santiprasitkul, Tepnimitr Judaeng.   

Abstract

OBJECTIVE: To develop a national evidence-based guidelines for the prevention and control of nosocomial infection. MATERIAL AND
METHOD: Draft guidelines for the prevention and control of nosocomial infection were developed by the researchers and reviewed by a 10 member panel of experts. The guidelines were modified by brainstorming of 55 practitioners in July 2002. The guidelines were tested for their applicability in 20 hospitals across the country in 2002. The participants gave suggestions on the guidelines which were modified accordingly. The guidelines were finalized by brainstorming of the 55 practitioners in August 2003.
RESULTS: National guidelines for the prevention and control of nosocomial infections were developed. Twenty-one topics were included. Modifications of the drafted guidelines were made four times according to the opinions of 10 experts, twice by brainstorming of 55 practitioners and by the suggestions of participants from 20 hospitals where they were tested. The practices in hospitals with different facilities were also suggested in the guidelines.
CONCLUSION: National guidelines for prevention and control of nosocomial infection were formulated. Their application for use in every hospital and periodic reviews are expected.

Entities:  

Mesh:

Year:  2005        PMID: 16850641

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  1 in total

1.  The value of intermittent point-prevalence surveys of healthcare-associated infections for evaluating infection control interventions at Angkor Hospital for Children, Siem Reap, Cambodia.

Authors:  N Stoesser; K Emary; S Soklin; K Peng An; S Sophal; S Chhomrath; N P J Day; D Limmathurotsakul; P Nget; Y Pangnarith; S Sona; V Kumar; C E Moore; N Chanpheaktra; C M Parry
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-02-14       Impact factor: 2.184

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.